GRO Biosciences is a biotechnology company that develops a protein therapeutics technology to improve treatments across multiple diseases.
GRO Biosciences has raised $60.3M in total funding. The most recent round was Series B. The last funding was announced in July 2024.
GRO Biosciences's investors include Alumni Ventures, National Science Foundation, Redmile Group, Digitalis Ventures, Pillar VC.
GRO Biosciences is headquartered in Boston, United States.
GRO Biosciences is a biotechnology company that develops a protein therapeutics technology to improve treatments across multiple diseases.
GRO Biosciences is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"GRO Biosciences — Funding & Investors." VCBacked, July 19, 2024, https://www.vcbacked.co/company/gro-biosciences. Accessed September 30, 2026.
VCBacked. (2024). GRO Biosciences — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/gro-biosciences
{{cite web |title=GRO Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/gro-biosciences |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated